Skip to main content

Current Challenges in Imaging-Based Cancer Screening, From the AJR Special Series on Screening.

Journal articles  - Journal Article, Review
Grimm, LJ; Kruse, DE; Tailor, TD; Johnson, KS; Allen, BC; Ryser, MD
Published in: AJR Am J Roentgenol
February 2026

The early detection of cancer confers many significant benefits for patients, primarily by enabling less invasive and more effective treatments and thus lowering disease mortality. Radiology is integral to early cancer detection, playing either a primary or complementary role in screening programs. Imaging-based screening is often performed in conjunction with other screening tests and may involve multiple modalities depending on patient demographics and cancer type. When a screening program for cancer early detection is being developed, both its potential benefits and harms need to be assessed. These harms, although specific to the modality and cancer, often include overdiagnosis, overtreatment, and false-positive examinations. As radiology technology improves and new tools become available, the risk-to-harm ratios of imaging-based screening will shift, and screening recommendations will need to adapt accordingly. Radiologists must be partners in the development and execution of screening guidelines to ensure the highest quality of care for patients. This review discusses the major challenges of cancer screening programs and guidelines, exploring sources of evidence as well as the harms of overdiagnosis and over-treatment. The article focuses on the most common cancer types that incorporate imaging-based screening, including lung cancer, breast cancer, colon cancer, prostate cancer, and hepatocellular carcinoma.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

AJR Am J Roentgenol

DOI

EISSN

1546-3141

Publication Date

February 2026

Volume

226

Issue

2

Start / End Page

e2532808

Location

United States

Related Subject Headings

  • Overdiagnosis
  • Nuclear Medicine & Medical Imaging
  • Neoplasms
  • Mass Screening
  • Humans
  • Early Detection of Cancer
  • Diagnostic Imaging
  • 3202 Clinical sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Grimm, L. J., Kruse, D. E., Tailor, T. D., Johnson, K. S., Allen, B. C., & Ryser, M. D. (2026). Current Challenges in Imaging-Based Cancer Screening, From the AJR Special Series on Screening. AJR Am J Roentgenol, 226(2), e2532808. https://doi.org/10.2214/AJR.25.32808
Grimm, Lars J., Danielle E. Kruse, Tina D. Tailor, Karen S. Johnson, Brian C. Allen, and Marc D. Ryser. “Current Challenges in Imaging-Based Cancer Screening, From the AJR Special Series on Screening.” AJR Am J Roentgenol 226, no. 2 (February 2026): e2532808. https://doi.org/10.2214/AJR.25.32808.
Grimm LJ, Kruse DE, Tailor TD, Johnson KS, Allen BC, Ryser MD. Current Challenges in Imaging-Based Cancer Screening, From the AJR Special Series on Screening. AJR Am J Roentgenol. 2026 Feb;226(2):e2532808.
Grimm, Lars J., et al. “Current Challenges in Imaging-Based Cancer Screening, From the AJR Special Series on Screening.” AJR Am J Roentgenol, vol. 226, no. 2, Feb. 2026, p. e2532808. Pubmed, doi:10.2214/AJR.25.32808.
Grimm LJ, Kruse DE, Tailor TD, Johnson KS, Allen BC, Ryser MD. Current Challenges in Imaging-Based Cancer Screening, From the AJR Special Series on Screening. AJR Am J Roentgenol. 2026 Feb;226(2):e2532808.

Published In

AJR Am J Roentgenol

DOI

EISSN

1546-3141

Publication Date

February 2026

Volume

226

Issue

2

Start / End Page

e2532808

Location

United States

Related Subject Headings

  • Overdiagnosis
  • Nuclear Medicine & Medical Imaging
  • Neoplasms
  • Mass Screening
  • Humans
  • Early Detection of Cancer
  • Diagnostic Imaging
  • 3202 Clinical sciences